SARS-CoV-2 Vascular & Multi-System Dysfunction Whitepaper

Home - vivalytic

SARS-CoV-2 Vascular & Multi-System Dysfunction Whitepaper

Randox Logo

30 June 2021

SARS-CoV-2 Vascular & Multi-System Dysfunction Whitepaper Download

COVID-19, the disease caused by SARS-CoV-2, is an infectious disease caused by a newly discovered coronavirus. While many of whom become infected by the disease will experience mild to moderate cold or flu-like symptoms, those with health complications – such as autoimmune diseases, asthma, heart disease and diabetes – are at risk of developing serious illness and adverse outcomes.

As of September 2021, over 228 million COVID-19 cases have been confirmed worldwide, with an estimated one in six patients experiencing complications which could be life threatening, with over £116 billion spent by the UK government alone on measures to combat the disease. This drastic spending has been mirrored across the globe, with the significant economic burden expected to be suffered for generations to come.

The whitepaper provides a brief overview of the COVID-19 pandemic, before discussing vascular abnormalities and associated complications brought on by the virus, such as multi-system disfunction, acute respiratory disease syndrome (ARDS) and hepatic, renal & cardiovascular function.

 

Want to know more about Randox?

Contact us or visit our homepage to view more.

Our COVID-19 Products and Services

HOME TEST

ANTIBODY TEST

TRAVEL CERTIFICATE

LABORATORY TOOLS


Vivalytic | Customer Support

Vivalytic | Customer Support

Molecular Diagnostics at the Point of Care

VIDEO TUTORIALS

For your support, we have compiled a series of informative video tutorials on how to install and operate the Vivalytic machine. You can use these guides to refresh your knowledge from prior training or to learn about specific procedures step by step.

Installation and Operator User Guide

Instructional Promo Video

COVID-19 Testing Process

Want to know more?

Contact us or visit our COVID-19 Monitoring & Management page

Related Products

Vivalytic Overview

SARS-CoV-2 Rapid Test

SARS-CoV-2 Pooling Test

Vivalytic Test Menu


Vivalytic | CoV Viral SARS-CoV-2 Test

Vivalytic | CoV

Viral SARS-CoV-2 (COVID-19) Testing

Detection of ORF1ab gene specific for SARS-CoV-2 and E gene specific for Sarbecovirus (confirmatory target)

  • null
    Detection from Biochip Technology (End-point PCR) via Nasopharyngeal and/or Oropharyngeal swab
  • null
    Detects both ORF1ab gene specific for SARS-CoV-2 and E gene specific for Sarbecovirus (confirmatory target)
  • null
    The Vivalytic CoV Viral SARS-CoV-2 test has recently received CE marketing
  • null
    Simple and easy to use analyser with a small footprint making it suitable for use in laboratory and non-laboratory settings
  • null
    Quick turnaround of 2.5 hours from sample entry to results
  • null
    Convenient 4 step process from sample entry to results. No laboratory training required

CoV is a rapid viral infection test for the detection of SARS-CoV-2 providing a clear and concise result in a timely manner direct at the point of care. Available on the Vivalytic, the CoV test cartridge detects both ORF1ab gene specific for SARS-CoV-2 and E gene specific for Sarbecovirus (confirmatory target), to report COVID-19 positive patient samples. This enables the patient to take the recommended safety precautions without delay.

Vivalytic Workflow

Intuitive engineering of Vivalytic ensures the analyser is user friendly. The process of patient sample to result comprises a very simple 4 step workflow.

To begin the test, the user scans or enters sample information. The cartridge code is then scanned into the embedded Vivalytic software. The user then adds sample into the dedicated cartridge slot, closes the lid and inserts the cartridge into the Vivalytic.

The touchscreen display will countdown the time remaining to test completion. Results will be displayed on the screen. Multiple Vivalytics can be wirelessly connected allowing the user to control multiple tests at one time all reporting to a master Vivalytic platform.

“AWARD-WINNING DESIGN DELIVERS
AN UNCOMPLICATED USER EXPERIENCE”

Download Vivalytic Brochure

Want to know more?

Contact us or visit our COVID-19 Monitoring & Management page

Related Products

Viral Respiratory Infection Array

SARS-CoV-2 Pooling Test

Vivalytic

Vivalytic Test Menu


Vivalytic | SARS-CoV-2 Pooling Test

Vivalytic | SARS-CoV-2 Pooling Test

Detecting SARS-CoV-2 (COVID-19)

Detecting SARS-CoV-2 (COVID-19) from up to 5 Pooled Samples Simultaneously

  • null
    Detection from real-time PCR via Nasopharyngeal and/or Oropharyngeal swab
  • null
    Up to 5 patient samples may be pooled and added to a single cartridge targeting the E gene sequence
  • null
    The SARS-CoV-2 pooling test has recently received CE marking
  • null
    Simple and easy to use POC analyser with a small footprint making it suitable for use in laboratory and non-laboratory settings
  • null
    Rapid turnaround from sample entry to result, capable of testing up to 160 samples a day
  • null
    Convenient 4 step process from sample entry to results. No laboratory training required

SARS-CoV-2 Pooling (COVID-19) is a rapid real time PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care. This enables the patient to take the recommended safety precautions without delay. The pooling could be done at the level of a ward, medical speciality, social bubble, or group of colleagues. It has potential for use in other settings, such as pre-operative screening, schools and universities, prisons, nursing homes, primary care, and large workplaces. Sample pooling allows more people to be tested quickly using fewer testing resources.

In collaboration with Bosch, we are proud to release not only a rapid testing solution for the detection of SARS-CoV-2 (COVID-19) but an accelerated mass testing solution to effectively and efficiently monitor and detect viral infection from the offset with an aim of minimising the rise in infections globally. The new SARS-CoV-2 pooling test will allow users to test up to 160 samples a day and has sensitivity of 98% and a specificity of 100% – a world’s first! Highly sensitive assays allow for laboratories to accurately detect low positive samples, enabling for effective identification of positive COVID-19 cases in a timely manner.

Vivalytic Workflow

Intuitive engineering of Vivalytic ensures the analyser is user friendly. The process of patient sample to result comprises a very simple 4 step workflow.

To begin the test, the user scans or enters sample information. The cartridge code is then scanned into the embedded Vivalytic software. The user then adds sample into the dedicated cartridge slot, closes the lid and inserts the cartridge into the Vivalytic.

The touchscreen display will countdown the time remaining to test completion. Results will be displayed on the screen. Multiple Vivalytics can be wirelessly connected allowing the user to control multiple tests at one time all reporting to a master Vivalytic platform.

“AWARD-WINNING DESIGN DELIVERS
AN UNCOMPLICATED USER EXPERIENCE”

Download Vivalytic Brochure

Want to know more?

Contact us or visit our COVID-19 Monitoring & Management page

Related Products

Viral Respiratory Infection Array

SARS-CoV-2 Rapid Test

Vivalytic

Vivalytic Test Menu


Vivalytic | Sexually Transmitted Infection Array

Vivalytic | Sexually Transmitted Infection Array

1 Sample | 1 Test | 10 Infections

Comprehensive Sexual Health Profile

  • null
    Detecting 10 bacterial, viral and protozoan infections
  • null
    Sample to answer, cartridge based molecular diagnostics at the point of care. Powered by Randox Biochip Technology
  • null
    The STI array has recently received CE marking
  • null
    Simple and easy to use analyser with a small footprint making it suitable for use in laboratory and non-laboratory settings
  • null
    Rapid turnaround time of just 2 hours from sample entry to result
  • null
    Convenient 4 step process from sample entry to results. No laboratory training required

The Sexually Transmitted Infection (STI) array is the broadest multiplex cartridge-based STI test on the market simultaneously detecting 7 bacterial,  2 viral and 1 protozoan infection for a comprehensive sexual health profile.

Globally, each day over 1 million people are exposed to an STI, many of who will not know they have an infection as many STI’s are asymptomatic whilst some individuals will display similar or overlapping symptoms, therefore co-infections may remain undiagnosed. Designed to offer a complete sexual health profile with an aim of prevention and control, the Vivalytic STI array can be used to diagnose existing infections whilst any identifying co-infections.

To find out more about the global economic burden of STIs and the impact of the COVID-19 pandemic on sexual health, download our most recent whitepaper that presents issues such as AMR, the development of super-gonorrhoea, and the challenges faced in a social and public concept due to the COVID-19 pandemic.

Vivalytic Workflow

Intuitive engineering of Vivalytic ensures the analyser is user friendly. The process of patient sample to result comprises a very simple 4 step workflow.

To begin the test, the user scans or enters sample information. The cartridge code is then scanned into the embedded Vivalytic software. The user then adds sample into the dedicated cartridge slot, closes the lid and inserts the cartridge into the Vivalytic.

The touchscreen display will countdown the time remaining to test completion. Results will be displayed on the screen. Multiple Vivalytics can be wirelessly connected allowing the user to control multiple tests at one time all reporting to a master Vivalytic platform.

Download Vivalytic Brochure
Download Whitepaper

“AWARD-WINNING DESIGN DELIVERS
AN UNCOMPLICATED USER EXPERIENCE”

Want to know more?

Contact us or visit our COVID-19 Monitoring & Management page

Related Products

Viral Respiratory Infection Array

Vivalytic Test Cartridges

Vivalytic

Vivalytic Test Menu


New 39-minute COVID test available on Randox-Bosch Vivalytic

News       About Us       SARS-CoV-2 Rapid Test

 

02 October 2020

 

New 39-minute COVID test available on Randox-Bosch Vivalytic

  • The world’s fastest PCR based SARS-CoV-2 test for the point of care delivers reliable results in 39 minutes.
  • Has a sensitivity of 98 percent and a specificity of 100 percent.
  • Simultaneous testing of five people with one cartridge by pooling will be available from early October.
  • Work is in progress to further reduce time to result.

A rapid new coronavirus test, which provides results for Covid-19 in just 39 minutes, is now available on the Vivalytic, a point of care platform brought to market by Randox Laboratories and Bosch.

The test for detection of the SARS-CoV-2 pathogen, is currently the fastest PCR test (the gold standard of test methods) worldwide, and is predestined for decentralized use in mobile test centres at service stations or in airports, so that people who take the test can obtain a reliable result while at the testing site.

Available now in Europe, the CE-approved test, which has a sensitivity of 98 percent and a specificity of 100 percent, helps avoid time in quarantine, relieve laboratories, and make travel and work safer again.

“Rapid and accurate testing plays a crucial role in identifying cases of Covid-19 – to contain any outbreaks and limit the spread of the virus,” says Dr. Heather McMillan, Molecular R&D Manager at Randox Biosciences.

 “This new rapid test will be a game-changer in the coronavirus testing landscape by allowing patients to receive their results at the point of care faster than ever before.”

Randox and Bosch launched the first rapid test for the Vivalytic analyser at the end of March, after just six weeks’ development.

As a multiplex test, it simultaneously checks samples for the SARS-CoV-2 virus as well as nine other respiratory diseases in two and a half hours, whereas the new accelerated test is exclusively for SARS-CoV-2.

“With our different coronavirus tests and variable analysis strategies, we open up a range of testing scenarios with a Vivalytic device – from screening all the way to supporting differential diagnosis for similar symptoms,” says Marc Meier, president of Bosch Healthcare Solutions GmbH.

And development work for Covid tests on the Vivalytic is ongoing: as of early October 2020, by pooling samples together it will be possible to simultaneously evaluate five samples in one test cartridge and at a comparable speed – a world first.

This will increase available testing capacity, by enabling fully automated processing of more than 160 samples a day using a Vivalytic device.

Key Benefits of SARS-CoV-2 test on Vivalytic point of care platform

The advantages of the rapid SARS-CoV-2 test on Vivalytic lie not only in speedy analysis, but also in ease of use. A sample is taken from the nose or throat using a swab, and placed in the test cartridge. Then the cartridge, which contains all the reagents required for the test, is inserted into the Vivalytic device for automated analysis.

  • Turnaround time of 39 mins from sample entry to result.
  • The SARS-CoV-2 rapid test has recently received CE marking.
  • The SARS-CoV-2 pooling test can run up to 5 samples on-board one single cartridge.
  • Easy 4-step user-friendly process from sample entry to result. Minimal training required.
  • Detection from real-time PCR from Nasopharyngeal and/or Oropharyngeal swab.
  • Suitable for use in any laboratory and non-laboratory settings.

The development of the new Vivalytic PCR singleplex test is part of a research and development project funded by the German Federal Ministry of Education and Research (BMBF).

For more information please contact marketing@randox.com

RESEARCH

BIOPHARMA

CLINICAL LAB

BIOREAGENTS


Vivalytic | Test Menu

Vivalytic | Test Menu

Detection at the Point Of Care

Detect Infections Now

  • null

    SARS-CoV-2

  • null

    Respiratory

  • null

    Genitourinary

  • null

    Hospital Acquired Infections

Respiratory

  • Virial Respiratory Infection
  • SARS-CoV-2 Rapid Test
  • SARS-CoV-2 Pooling
  • Respiratory Tract Infection
  • Flu A, B, & RSV
  • Chronic Lung Disease

VIRUSES
SARS-CoV-2 (COVID-19)Sarbecovirus
(SARS, SARS like, SARS-CoV-2)
Influenza A
Coronavirus 229E/NL63Adenovirus A/B/C/D/EInfluenza B
Coronavirus OC43/HKUIEnterovirus A/B/CRhinovirus A/B
Middle East Respiratory
Syndrome Coronavirus (MERS-CoV)
VIRUSES
SARS-CoV-2 (COVID-19)
VIRUSES
SARS-CoV-2 (COVID-19)

 

VIRUSES
Influenza ACoronavirus OC43/HKUIParainfluenza virus 3
Influenza BEnterovirus A/B/CParainfluenza virus 4
Adenovirus A/B/C/D/EMetapneumovirusRespiratory syncytial virus A/B
Bocavirus 1/2/3Parainfluenza virus 1Rhinovirus A/B/C
Coronavirus 229E/NL63Parainfluenza virus 2
BACTERIA
Bordetella parapertussis Haemophilus influenzaeMycoplasma pneumoniae
Bordetella pertussisLegionella pneumophilaStreptococcus pneumoniae
Chlamydophila pneumoniaeMoraxella catarrhalis
VIRUSES
Influenza AInfluenza BRespiratory Syncytial Virus (RSV)
VIRUSES
AdenovirusRespiratory syncytial virus BInfluenza B
MetapneumovirusRhinovirus A/B/C
Respiratory syncytial virus AInfluenza virus A
BACTERIA
Achromobacter xylosoxidans Moraxella catarrhalis Pseudomonas aeruginosa
Bordetella pertussis Mycoplasma pneumoniae Staphylococcus aureus
Burkholderia cepacia complex (21 spp) Non-tuberculous mycobacterium (15 spp Stenotrophomonas maltophila
Burkholderia Cenocepacia Mycobacterium abscessus subgroup (4 spp) Streptococcus pneumoniae (21spp)
Burkholderia multivorans Mycobacterium avium complex (4 spp) Streptococcus species (19 spp)
Chlamydia pneumoniae Pandoraea species (5spp) Veillonella species (3 spp)
Haemophilus influenza Prevotella species (16 spp)
FUNGI
Aspergillus fumigatus Candida albicans Exophialia dermatitidis
Scedosporium species (7 spp)
ANTIBIOTIC RESISTANCE MARKERS
mecA (incl MRSA)

Genitourinary

  • Sexually Transmitted Infection
  • Urinary Tract Infection
VIRUSES
Neisseria Gonorrhoeae (NG)Haemophilus Ducreyi (HD)
Mycoplasma Genitalium (MG)Mycoplasma Hominis (MH)
Ureaplasma Urealyticum (UU)Treponema Pallidum (TP)
Chlamydia Trachomatis (CT)Herpes Simplex virus 1(HSV-1)
Trichomonas Vaginalis (TV)Herpes Simplex virus 2(HSV-2)
BACTERIA
Citrobacter freundii Klebsiella oxytoca Serratia marcescens
Citrobacter koseri Klebsiella pneumoniae Staphylococcus aureus
Klebsiella aerogenes Morganella morganii Staphylococcus epidermidis
Enterobacter cloacae Proteus spp. Staphylococcus saprophyticus
Enterococcus faecalis Pseudomonas aeruginosa Streptococcus agalactiae (GBS)
Enterococcus faecium Providencia rettgeri
FUNGUS
Candida albicans
ANTIOBIOTIC RESISTANCE MARKERS
mecA (incl MRSA) Trimethoprim Resistance 3 Van A (Vancomycin Resistance A)
Trimethoprim Resistance 1 Trimethoprim Resistance 4 Van B (Vancomycin Resistance B)
Trimethoprim Resistance 2 Trimethoprim Resistance 5

Hospital Acquired Infections

  • MRSA
BACTERIA
Methicillin-resistant Staphylococcus aureus (MRSA)Methicillin-sensitive Staphylococcus aureus (MSSA) Methicillin-resistant coagulase-negative Staphylococci (MRCoNS)

Want to know more?

Contact us or visit our COVID-19 Monitoring & Management page

Related Products

Vivalytic Testing Cartridges

VRI Array

Vivalytic

SARS-CoV-2 Rapid Test


Vivalytic | Test Cartridges

Vivalytic | Cartridges

Powered by Biochip Technology

Simple & Accurate POC Molecular Diagnostics

  • null
    Unique test menu covering a diverse range of respiratory, genitourinary and hospital acquired infections including SARS-CoV-2 (COVID-19)
  • null
    Multiplex technology allows for the detection of multiple targets from a single patient sample
  • null
    All reagents are on-board vivalytic cartridges
  • null
    Vivalytic cartridges are capable of target detection from multiple sample types Urine, Nasopharyngeal or Oropharyngeal Swab & Sputum
  • null
    Vivalytic cartridges are suitable for use at room temperature
  • null
    Vivalytic cartridges provide users with minimal risk contamination

Vivalytic cartridges are compact, technologically advanced Molecular Diagnostic tests utilising micro-fluidics to enable simple and accurate diagnostic testing. Vivalytic cartridges are powered by a variety of technologies, dependent upon the test application. Hi-Plex and Lo-Plex tests can be analysed on the Vivalytic. Hi-Plex tests utilise Randox patented Biochip Array Technology, enabling end-point qualitative PCR and providing multiple test results from each sample. Lo-Plex tests are based on a variety of detection methods including real-time qualitative PCR and melting curve analysis.

Randox patented Biochip Technology allows simultaneous detection of multiple targets from a single patient sample. The biochip detection system is based on a chemiluminescent signal, this is the emission of light, without heat, as a result of a chemical reaction. Each biochip is prefabricated with spatially discrete testing regions (DTR’s).

Each DTR represents an individual test. Each DTR can be occupied with oligonucleotides specific to a pathogen or target of interest. The Hi-Plex capabilities of Biochip Technology eliminates the need to run multiple time consuming and sample intensive assays.

An enzyme is used to catalyse the chemical reaction of the biochip which generates the chemiluminescent signal. The light emitted from the chemiluminescent reaction that takes place in each DTR is simultaneously detected and quantified using a Charge – Coupled Device (CCD) Camera. This CCD Camera simultaneously records the light emission from all the DTRs on each biochip. The Vivalytic automatically generates a result report for all targets.

Want to know more?

Contact us or visit our COVID-19 Monitoring & Management page

Related Products

SARS-CoV-2 Rapid Test

VRI Array

Vivalytic

Vivalytic Test Menu


Vivalytic | SARS-CoV-2 Rapid 39 Minute Test

Vivalytic | SARS-CoV-2 Rapid 39 Minute Test

Detecting SARS-CoV-2 (COVID-19)

Rapidly Detecting SARS-CoV-2 (COVID-19)

  • null
    Detection from real-time PCR via Nasopharyngeal and/or Oropharyngeal swab
  • null
    The SARS-CoV-2 rapid test targets the E gene sequence for COVID-19 detection
  • null
    The SARS-CoV-2 rapid test has recently received CE marking
  • null
    Simple and easy to use analyser with a small footprint making it suitable for use in laboratory and non-laboratory settings
  • null
    Rapid turnaround time of just 39 mins from sample entry to result
  • null
    Convenient 4 step process from sample entry to results. No laboratory training required

SARS-CoV-2 (COVID-19) is a rapid real time PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care. This enables the patient to take the recommended safety precautions without delay.

In collaboration with Bosch, we are proud to release not only a rapid testing solution for the detection of SARS-CoV-2 (COVID-19) but an accelerated mass testing solution to effectively and efficiently monitor and detect viral infection from the offset with an aim of minimising the rise in infections globally. The new SARS-CoV-2 pooling test will allow users to test up to 160 samples a day and has sensitivity of 98% and a specificity of 100% – a world’s first!

Vivalytic Workflow

Intuitive engineering of Vivalytic ensures the analyser is user friendly. The process of patient sample to result comprises a very simple 4 step workflow.

To begin the test, the user scans or enters sample information. The cartridge code is then scanned into the embedded Vivalytic software. The user then adds sample into the dedicated cartridge slot, closes the lid and inserts the cartridge into the Vivalytic.

The touchscreen display will countdown the time remaining to test completion. Results will be displayed on the screen. Multiple Vivalytics can be wirelessly connected allowing the user to control multiple tests at one time all reporting to a master Vivalytic platform.

“AWARD-WINNING DESIGN DELIVERS
AN UNCOMPLICATED USER EXPERIENCE”

Download Vivalytic Brochure

Want to know more?

Contact us or visit our COVID-19 Monitoring & Management page

Related Products

Viral Respiratory Infection Array

SARS-CoV-2 Pooling Test

Vivalytic

Vivalytic Test Menu


Vivalytic | The All in One Molecular Solution

Vivalytic | All In One Molecular Solution

Molecular Diagnostics at the Point of Care

Why Choose the Vivalytic?

  • null
    Fully automated, sample to answer point of care diagnostics
  • null
    Full molecular workflow consolidated into one small benchtop platform
  • null
    Unique test menu covering a diverse range of respiratory, genitourinary and hospital acquired infections including SARS-CoV-2 (COVID-19)
  • null
    Hi-Plex & Lo-Plex Capabilities. Powered by Randox Biochip Technology enabling multiple results from one patient sample
  • null
    Wireless connectivity, no peripherals required making Vivalytic a unique space-saving & hygienic solution
  • null
    Easy 4 step process from sample entry to results. No laboratory training required
The Vivalytic platform is a universal, fully automated all in one solution for molecular diagnostics. It is a cartridge-based platform enabling Hi-Plex and Lo-Plex testing developed in partnership with Bosch. Vivalytic consolidates the full molecular workflow into a small benchtop platform, capable of extraction, PCR amplification and detection. Randox multiplex Biochip Technology powers Vivalytic enabling multiple results from one patient sample. Randox patented Biochip Technology allows simultaneous detection of multiple targets from a single patient sample. The biochip detection system is based on a chemiluminescent signal, this is the emission of light, without heat, as a result of a chemical reaction. Each biochip is prefabricated with spatially discrete testing regions (DTR’s). Each DTR represents an individual test. Each DTR can be occupied with oligonucleotides specific to a pathogen or target of interest. The Hi-Plex capabilities of Biochip Technology eliminates the need to run multiple time consuming and sample intensive assays.

Vivalytic Test Menu

  • SARS-CoV-2 Rapid Test
  • SARS-CoV-2 Pooling
  • CoV
  • Virial Respiratory Infection
  • Chronic Lung Disease
  • MRSA
  • Respiratory Tract Infection
  • Flu A, B, & RSV
  • STI
  • Urinary Tract Infection
VIRUSES
SARS-CoV-2 (COVID-19)
VIRUSES
SARS-CoV-2 (COVID-19)

 

VIRUSES
SARS-CoV-2 (COVID-19)Sarbecovirus (SARS, SARS like, SARS-CoV-2)

VIRUSES
SARS-CoV-2 (COVID-19)Sarbecovirus
(SARS, SARS like, SARS-CoV-2)
Influenza A
Coronavirus 229E/NL63Adenovirus A/B/C/D/EInfluenza B
Coronavirus OC43/HKUIEnterovirus A/B/CRhinovirus A/B
Middle East Respiratory
Syndrome Coronavirus (MERS-CoV)
VIRUSES
AdenovirusRespiratory syncytial virus BInfluenza B
MetapneumovirusRhinovirus A/B/C
Respiratory syncytial virus AInfluenza virus A
BACTERIA
Achromobacter xylosoxidans Moraxella catarrhalis Pseudomonas aeruginosa
Bordetella pertussis Mycoplasma pneumoniae Staphylococcus aureus
Burkholderia cepacia complex (21 spp) Non-tuberculous mycobacterium (15 spp Stenotrophomonas maltophila
Burkholderia Cenocepacia Mycobacterium abscessus subgroup (4 spp) Streptococcus pneumoniae (21spp)
Burkholderia multivorans Mycobacterium avium complex (4 spp) Streptococcus species (19 spp)
Chlamydia pneumoniae Pandoraea species (5spp) Veillonella species (3 spp)
Haemophilus influenza Prevotella species (16 spp)
FUNGI
Aspergillus fumigatus Candida albicans Exophialia dermatitidis
Scedosporium species (7 spp)
ANTIBIOTIC RESISTANCE MARKERS
mecA (incl MRSA)
BACTERIA
Methicillin-resistant Staphylococcus aureus (MRSA)Methicillin-sensitive Staphylococcus aureus (MSSA) Methicillin-resistant coagulase-negative Staphylococci (MRCoNS)
VIRUSES
Influenza ACoronavirus OC43/HKUIParainfluenza virus 3
Influenza BEnterovirus A/B/CParainfluenza virus 4
Adenovirus A/B/C/D/EMetapneumovirusRespiratory syncytial virus A/B
Bocavirus 1/2/3Parainfluenza virus 1Rhinovirus A/B/C
Coronavirus 229E/NL63Parainfluenza virus 2
BACTERIA
Bordetella parapertussis Haemophilus influenzaeMycoplasma pneumoniae
Bordetella pertussisLegionella pneumophilaStreptococcus pneumoniae
Chlamydophila pneumoniaeMoraxella catarrhalis
VIRUSES
Influenza AInfluenza BRespiratory Syncytial Virus (RSV)
VIRUSES
Neisseria Gonorrhoeae (NG)Haemophilus Ducreyi (HD)
Mycoplasma Genitalium (MG)Mycoplasma Hominis (MH)
Ureaplasma Urealyticum (UU)Treponema Pallidum (TP)
Chlamydia Trachomatis (CT)Herpes Simplex virus 1(HSV-1)
Trichomonas Vaginalis (TV)Herpes Simplex virus 2(HSV-2)
BACTERIA
Citrobacter freundii Klebsiella oxytoca Serratia marcescens
Citrobacter koseri Klebsiella pneumoniae Staphylococcus aureus
Klebsiella aerogenes Morganella morganii Staphylococcus epidermidis
Enterobacter cloacae Proteus spp. Staphylococcus saprophyticus
Enterococcus faecalis Pseudomonas aeruginosa Streptococcus agalactiae (GBS)
Enterococcus faecium Providencia rettgeri
FUNGUS
Candida albicans
ANTIOBIOTIC RESISTANCE MARKERS
mecA (incl MRSA) Trimethoprim Resistance 3 Van A (Vancomycin Resistance A)
Trimethoprim Resistance 1 Trimethoprim Resistance 4 Van B (Vancomycin Resistance B)
Trimethoprim Resistance 2 Trimethoprim Resistance 5

Vivalytic Workflow

Intuitive engineering of Vivalytic ensures the analyser is user friendly. The process of patient sample to result comprises a very simple 4 step workflow.

To begin the test, the user scans or enters sample information. The cartridge code is then scanned into the embedded Vivalytic software. The user then adds sample into the dedicated cartridge slot, closes the lid and inserts the cartridge into the Vivalytic.

The touchscreen display will countdown the time remaining to test completion. Results will be displayed on the screen. Multiple Vivalytics can be wirelessly connected allowing the user to control multiple tests at one time all reporting to a master Vivalytic platform.

“AWARD-WINNING DESIGN DELIVERS
AN UNCOMPLICATED USER EXPERIENCE”

Download Vivalytic Brochure

Want to know more?

Contact us or visit our COVID-19 Monitoring & Management page

Related Products

VRI Array

SARS-CoV-2 Rapid Test

SARS-CoV-2 Pooling Test

Vivalytic Test Menu


Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Quality Control
×
Make an Enquiry
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Biochip
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Molecular
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Future Diagnostics
×
Make an Enquiry - RX series (Product)
×
Make an Enquiry - Quality Control
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - RIQAS
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.